A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital

被引:27
作者
Cohen, Stephanie A. [1 ]
Nixon, Dawn M. [1 ]
机构
[1] St Vincent Hlth, Canc Genet Risk Assessment Program, 8402 Harcourt Rd 200, Indianapolis, IN 46260 USA
关键词
Genetic counseling; Hereditary cancer risk assessment; Genetic counselor extenders; Access; BRCA-RELATED CANCER; HEREDITARY BREAST; ADVERSE EVENTS; WOMEN; SUSCEPTIBILITY; GUIDELINES; MANAGEMENT; ANGELINA; IDENTIFICATION; PROFESSIONALS;
D O I
10.1007/s10549-016-3964-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to evaluate a unique approach to cancer risk assessment for improved access by smaller rural communities. Local, on-site nurse navigators were trained and utilized as genetic counselor extenders (GCEs) to provide basic risk assessment and offer BRCA1/2 genetic testing to select patients based on a triaging process in collaboration with board-certified genetic counselors (CGCs). From August 2012 to July 2014, 12,477 family history questionnaires representing 8937 unique patients presenting for a screening mammogram or new oncology appointment were triaged. Of these, 8.2 % patients were identified at increased risk for hereditary breast cancer, and 4.2 % were identified at increased risk for other hereditary causes of cancer. A total of 75 of 1130 at-risk patients identified (6.6 %) completed a genetic risk assessment appointment; 23 with a GCE and 52 with a CGC. A review of the completed genetic test requisition forms from a 9-year pre-collaboration time period found that 16 % (20/125) did not appear to meet genetic testing criteria. Overall, there was a fourfold increase in patients accessing genetic services in this study period compared to the pre-collaboration time period. Efficiency of this model was assessed by determining time spent by the CGC in all activities related to the collaboration, which amounted to approximately 16 h/month. Adjustments have been made and the program continues to be monitored for opportunities to improve efficiency. This study demonstrates the feasibility of CGCs and GCEs collaborating to improve access to quality services in an efficient manner.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 47 条
[1]   Hereditary Breast and Ovarian Cancer Syndrome [J].
不详 .
GYNECOLOGIC ONCOLOGY, 2009, 113 (01) :6-11
[2]   Further development and evaluation of a breast/ovarian cancer genetics referral screening tool [J].
Bellcross, Cecelia .
GENETICS IN MEDICINE, 2010, 12 (04) :240-240
[3]   Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population [J].
Bellcross, Cecelia A. ;
Lemke, Amy A. ;
Pape, Laura S. ;
Tess, Angela L. ;
Meisner, Lorraine T. .
GENETICS IN MEDICINE, 2009, 11 (11) :783-789
[4]   BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].
Berry, DA ;
Iversen, ES ;
Gudbjartsson, DF ;
Hiller, EH ;
Garber, JE ;
Peshkin, BN ;
Lerman, C ;
Watson, P ;
Lynch, HT ;
Hilsenbeck, SG ;
Rubinstein, WS ;
Hughes, KS ;
Parmigiani, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712
[5]   Adverse Events in Cancer Genetic Testing: The Third Case Series [J].
Bonadies, Danielle C. ;
Brierley, Karina L. ;
Barnett, Rachel E. ;
Baxter, Melanie D. ;
Donenberg, Talia ;
Ducaine, Whitney L. ;
Ernstx, Michelle E. ;
Homer, Jeanne ;
Judkins, Megan ;
Lovick, Niki M. ;
Powers, Jacquelyn M. ;
Stanislaw, Christine ;
Stark, Elizabeth ;
Stenner, Rio C. ;
Matloff, Ellen T. .
CANCER JOURNAL, 2014, 20 (04) :246-253
[6]  
Bookman T., 2016, Kaiser health news
[7]   The Angelina effect: immediate reach, grasp, and impact of going public [J].
Borzekowski, Dina L. G. ;
Guan, Yue ;
Smith, Katherine C. ;
Erby, Lori H. ;
Roter, Debra L. .
GENETICS IN MEDICINE, 2014, 16 (07) :516-521
[8]   Adverse Events in Cancer Genetic Testing Medical, Ethical, Legal, and Financial Implications [J].
Brierley, Karina L. ;
Blouch, Erica ;
Cogswell, Whitney ;
Homer, Jeanne P. ;
Pencarinha, Debbie ;
Stanislaw, Christine L. ;
Matloff, Ellen T. .
CANCER JOURNAL, 2012, 18 (04) :303-309
[9]  
Brierley Karina L, 2010, Conn Med, V74, P413
[10]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406